arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

EUDA Health Holdings Ltd

EUDA

$16.10 ▼ -0.73 (-4.34%) at close

6 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

EUDA Health Holdings Ltd faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $30.1M

Dividend Yield —

Revenue Growth 70.0% ↗

Op. Margin -36.3% ↗

ROIC 59.1% ↘

FCF / Share $-1.34 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.82M

↑ +70.0% —

Net Income Profit after all expenses

$-2.77M

↑ +81.9% —

Operating Margin Operating profit as % of sales

-36.3%

↑ +91.6% 7th

FCF / Share Free cash flow per share

$-1.34

↓ -1941.5% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	70.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+775%)	8.2% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	-62.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-879%)	-6.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-183%)	—	—
EPS Growth YoY (%)	-214.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	78.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—
Net Income Growth YoY (%)	81.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-53.0% Weak Weak Year-over-year change in net income	59.7% Excellent Excellent Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	-1941.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	48.5% Excellent Excellent Year-over-year change in free cash flow	0.8% Caution Caution Year-over-year change in free cash flow	N/M	—	—
Revenue CAGR 3Y (%)	-11.5% Weak Weak Compound annual revenue growth over 3 years	-27.5% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-36.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-342%)	-432.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2981%)	-106.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-812%)	-122.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-917%)	-11.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-178%)	—
Effective Tax Rate (%) (%)	-1.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-40.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-439%)	-382.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3291%)	-270.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2357%)	-252.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2207%)	8.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-32%)	—
FCF Margin (%) (%)	-36.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-53.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-78.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-15.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	4.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	59.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	678.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	41.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	342.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-223.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-144.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1021.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-302.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-47.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	65.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+334%)	—	133.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+793%)	—	165.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1006%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-413.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-313.01x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-226.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-615.57x Weak Weak Operating income divided by interest expense Optimal: > 5x	-11.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	—	$-143.02K	$-190.00K	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$3.65	$0.12	$0.16	$0.82	$1.14	—
Basic EPS, GAAP (USD)	$-1.48	$-0.47	$-0.44	$-2.07	$0.09	—
Free Cash Flow per Share (USD)	$-1.34	$-0.07	$-0.13	$-0.13	$0.05	—
Book Value per Share (USD)	$-2.25	$-0.07	$-0.30	$-2.35	$0.06	—
Tangible Book Value per Share (USD)	$-2.34	$-0.08	$-0.30	$-2.35	$-0.08	—
Basic Weighted Avg Shares (shares)	1.87M	32.46M	22.90M	12.03M	9.25M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-4.80M	$-3.38M	$-7.99M	$-4.09M	$-2.96M	—
Total Equity (USD)	$-4.25M	$-2.55M	$-7.50M	$-3.52M	$521.23K	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$6.82M	$4.01M	$3.71M	$9.84M	$10.54M	—
Depreciation Expense (USD)	$38.55K	$22.11K	$4.89K	$23.35K	$34.52K	—
Net Income, GAAP (USD)	$-2.77M	$-15.36M	$-10.04M	$-24.88M	$864.83K	—
Operating Cash Flow (USD)	$-2.43M	$-2.03M	$-2.92M	$-1.53M	$443.92K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 14 quarters

EUDA Health Holdings Ltd

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare EUDA with peers